Xcout IntelPharos iBio competitors & alternatives
The 12 closest competitors and alternatives to Pharos iBio among biotechnology companies — ranked by similarity to what Pharos iBio actually does, not by market-cap band.
Subscribe to see Pharos iBio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Pharos iBio
Pharos iBio Co., Ltd. is a South Korean biotechnology company that uses artificial intelligence and big-data approaches for drug discovery and development. Its pipeline includes oncology candidates such as PHI-101, a FLT3 inhibitor being developed for acute myeloid leukemia and other cancers, serving patients with difficult-to-treat diseases and pharmaceutical development partners.
Pharos iBio at a glance
Pharos iBio is a biotechnology company headquartered in South Korea. It has raised at least $15.9M across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Debt, closed in December 2025.
Pharos iBio funding rounds
At least $15.9M raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Debt | Undisclosed | — | |
| — | $15.9M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Pharos iBio competitors
Ranked by semantic similarity — how close each company is to Pharos iBio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
Similar biotechnology company
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities. Established in 2013, the company operates from its headquarters in Dallas, Texas.
Biotech
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Similar biotechnology company
Great Bay Bio is a biotech company headquartered in HKSTP that drives drug development using cutting-edge technologies such as AI and big data mining.
Similar biotechnology company
Sightera Biosciences is an Antwerp-based biotechnology startup leveraging clinically correlated patient data and an artificial intelligence platform to advance drug discovery and design.
Biotech
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Biotech
LabGenius Ltd is a biotechnology company (also known as LabGenius Therapeutics) that utilizes machine learning and automation to discover and develop novel protein therapeutics. The company collaborates with major pharmaceutical partners, such as LG Chem, to advance research and development activities.
Similar biotechnology company
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Similar biotechnology company
Reverie Labs is a Cambridge, Massachusetts-based biotechnology company founded in 2017 that applied machine learning to drug discovery and developed brain-penetrant cancer therapies. In its operations, the company focused on accelerating preclinical drug development through lead generation and optimization using machine learning models and software.
Biotech
Insitro is a physical artificial intelligence company headquartered in South San Francisco, California, that uses machine learning and data at scale to build a different kind of drug company.
Healthtech
FinalDose is a biotechnology research company headquartered in San Francisco, United States. It is developing the first programmable drug platform, which involves a single smart drug molecule designed to find diseased cells by their DNA for cancer therapy.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Pharos iBio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pharos iBioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →